Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
3.740
-0.360 (-8.78%)
Sep 15, 2026, 4:00 PM EDT - Market closed
Evolent Health Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,097 | 1,876 | 2,555 | 1,964 | 1,352 | 907.96 |
Revenue Growth | -4.50% | -26.56% | 30.09% | 45.26% | 48.91% | -1.80% |
Gross Profit Gross Profit Growth | 361.64 | 399.88 | 367.35 | 460.47 | 316.58 | 250.41 |
Operating Income Operating Income Growth | -27.84 | -4.44 | 23.94 | 14.18 | -19.88 | -17.41 |
Net Income Net Income Growth | -511.06 | -579.4 | -93.45 | -142.26 | -19.16 | -37.6 |
Earnings Per Share EPS Growth | -4.54 | -5.07 | -0.81 | -1.28 | -0.20 | -0.44 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medicaid Medicaid Growth | 872.79 | 818.31 | 862.4 | 785.05 | 559.36 | 421.07 |
Medicare Medicare Growth | 627.98 | 464.24 | 1,046 | 708.85 | 458.41 | 407.33 |
Commercial and Other Commercial and Other Growth | 596.25 | 593.68 | 646.42 | 469.99 | 334.24 | 79.56 |
Revenue (Total) Revenue (Total) Growth | 2,097 | 1,876 | 2,555 | 1,964 | 1,352 | 907.96 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 115.7 | 151.86 | 104.2 | 192.83 | 188.2 | 266.28 |
Total Debt Total Debt Growth | 970.43 | 989.7 | 713.67 | 644.8 | 476.12 | 280.47 |
Net Cash (Debt) Net Cash Growth | -854.73 | -837.84 | -609.47 | -451.97 | -287.92 | -14.19 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -7.60 | -7.34 | -5.31 | -4.06 | -3.07 | -0.16 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 54.32 | 38.84 | 18.77 | 142.58 | -11.55 | 38.75 |
Capital Expenditures CapEx Growth | 26.07 | -34.09 | -33.12 | -28.75 | -47.53 | -27.5 |
Free Cash Flow Free Cash Flow Growth | 80.39 | 4.76 | -14.35 | 113.84 | -59.08 | 11.25 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 17.24% | 21.31% | 14.38% | 23.45% | 23.42% | 27.58% |
Operating Margin | -1.33% | -0.24% | 0.94% | 0.72% | -1.47% | -1.92% |
Pretax Margin | -23.95% | -28.50% | -2.47% | -10.31% | -4.59% | -3.28% |
Profit Margin | -24.37% | -30.88% | -3.66% | -7.24% | -1.42% | -4.14% |
FCF Margin | 3.83% | 0.25% | -0.56% | 5.80% | -4.37% | 1.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 10.69 | 16.88 | 13.66 | 38.40 | 44.32 | 57.19 |
P/FCF Ratio | 5.26 | 93.88 | - | 33.36 | - | 216.09 |
PS Ratio | 0.20 | 0.24 | 0.51 | 1.93 | 2.07 | 2.68 |